Page results
-
We offer an expert service for complex pulmonary embolic disease (PED) and follow up for all cases diagnosed with this condition at UCLH.
-
We provide a specialist service for the assessment and treatment of sarcoidosis as part of the interstitial lung disease (ILD) service at UCLH. We provide holistic multidisciplinary care, with a weekly consultant-led outpatient clinic and clinical nurse specialist support.
-
UCLH provides a comprehensive service to diagnose, treat and support people with cancer. We are a specialist centre for many types of cancer and treat patients from both our local area and across the country.
-
The oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
The lymphoedema service at UCLH provides assessment, diagnosis, treatment and management of cancer-related lymphoedema.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
UCLH is a specialist centre for the treatment of urological cancers.
-
The heart failure service provides comprehensive care for patients with heart failure.
File results
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0339 - PACS, VNA, RIS, digital pathology and cardiology PACS systems
-
FOI/2024/0344 - Cancer diagnosis following A&E attendance 2018-2023
-
FOI/2024/0341 - Robotic Process Automation (RPA)/ Intelligent Automation (IA) technology at Trust
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities